Mostra i principali dati dell'item

dc.creatorGoulis, I.en
dc.creatorAkriviadis, E.en
dc.creatorKaratapanis, S.en
dc.creatorDeutsch, M.en
dc.creatorDalekos, G.en
dc.creatorRaptopoulou-Gigi, M.en
dc.creatorDrakoulis, C.en
dc.creatorBakalos, G.en
dc.creatorPapatheodoridis, G.en
dc.date.accessioned2015-11-23T10:28:50Z
dc.date.available2015-11-23T10:28:50Z
dc.date.issued2011
dc.identifier.issn0168-8278
dc.identifier.urihttp://hdl.handle.net/11615/28104
dc.source.uri<Go to ISI>://WOS:000297625601292
dc.subjectGastroenterology & Hepatologyen
dc.titleHBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORTen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item